HSP60 peptide treatment of Type 1 Diabetes: translating a basic observation into a successful phase 3 clinical trial.

Nov 13, 2012 (Tue) | 4:15 PM -5:15 PM
Alway M106 : Stanford, CA

Department:  Immunology

Contact: Nicki Barnes | 6-1980 | nbarnes@stanford.edu

Presenter(s):

  • Irun Cohen Weizmann Institute of Science